ESH eLearning

WELCOME
Welcome to the ESH eLearning Centre!
  • Our goal is to share knowledge regarding the world of haematology.
  • With our conferences, we connect professionals all around the world.
  • With this platform, we allow everyone to relive the talks and discussions of our events for free!

Welcome to the ESH eLearning Centre!

ESH believes it is very important to allow specialists to gain new knowledge, competencies, and skills or to brush up on acquired ones at a time and place of their choosing.
 

The ESH eLearning platform comprises freely accessible:

→ on-demand components from ESH Conferences (slide bank, video presentations/ webcast, and discussions) ; whether you cannot attend live events because of time, mobility, financial or other restraints, or you simply wish to review content presented at a session you attended

→ as well as quizzes, learning tools, interviews, abstracts, documents and articles.
 

Stay updated:

→ Sign up for ESH Newsletter

→ Follow us on ESH social media (X, Facebook, LinkedIn)
UPCOMING CONFERENCES
The upcoming ESH conferences
  • February 16-18, 2025: 5th Scientific Workshop: the Haematological Tumour Microenvironment and its Therapeutic Targeting
  • March 7-9, 2025: 4th How to Diagnose and Treat: CML/MPN
  • March 14-16, 2025: 4th Translational Research Conference: Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia
  • Click to discover all the other upcoming ESH conferences

ESH provides a diverse portfolio of leading-edge scientific, translational research and clinically oriented meetings at which outstanding international faculties actively inform, mentor and interact face to face with practicing biologists and clinicians from across the world.  

→ Ample time is deliberately provided for in-depth scientific discussion and interaction. 

→ Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks.

→ ESH conference delegates are invited to submit abstracts. Selected abstracts are presented as brief oral communications or posters.

 

ESH upcoming agenda comprises:

- Scientific Workshops: 

→ organized in rapidly evolving scientific fields
 

- Translational Research Conferences:

→ disease-specific
→  focus on leading-edge basic, clinical and therapeutic research and future perspectives. 

→ the presentation of unpublished data is encouraged.
 

- “How to Diagnose and Treat” Conferences:

→ disease-specific
→ emphasize clinical management, including future perspectives

→ use case-based lectures to stimulate interaction
SPECIFIC DISEASES
Browse content by your topic(s) of interest
  • Leukaemias
  • Myelomas
  • Immune therapies and others…
STAY TUNED
OPEN CONTENT
  • Find all our open content without logging-in
3rd Translational Research Conference on BONE MARROW FAILURE AND LEUKAEMIA PREDISPOSITION SYNDROMES
ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes
  • Chairs : Carmem Bonfim, Tim Brümmendorf, Antonio Risitano, Sharon Savage
  • November 15-17, 2024 - Paris, France

​SCIENTIFIC TOPICS:

- Stem cell biology
- Inherited predisposition to leukaemia
- Constitutional marrow failure 2
- Constitutional marrow failure 3: telomere biology diseases and others…
- AA & PNH: 1. Pathophysiology and diagnosis
- AA & PNH: 2. CHIP and clonal evolution in BMFS
- Treatment of aplastic anaemia
- Treatment of paroxysmal nocturnal haemoglobinuria
- Expanding areas in BMFS

 

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from February 17th, 2025!

 

​FACULTY MEMBERS:

Andrea Bacigalupo (Rome), Fabian Beier (Aachen), Sigbjorn Berentsen (Haugesund), Carmem Bonfim (Durham), Tim Brümmendorf (Aachen), Pedro Henrique De Lima Prata (Limoges), Beatrice Drexler (Basel), Carlo Dufour (Genova), Miriam Erlacher (Freiburg), Miguel Godinho Ferreira (Nice), Simone Feurstein (Heidelberg), Morag Griffin (Leeds), Britta Höchsmann (Ulm), Deena Iskander (London), Austin Kulasekararaj (London), Thierry Leblanc (Paris), Coleman Lindsley (Boston), Jaroslaw Maciejewski (Cleveland), Lisa McReynolds (Bethesda), Maurizio Miano (Genova), Michael Milsom (Heidelberg), Satu Mustjoki (Helsinki), Marena Niewisch (Hannover), Simona Pagliuca (Nancy), Régis Peffault de Latour (Paris), Antonio Risitano (Avellino), Sharon Savage (Bethesda), Hubert Schrezenmeier (Ulm), Gérard Socié (Paris), Jean Soulier (Paris), Ronald Taylor (Charlottesville), Valeria Visconte (Cleveland), Alan Warren (Cambridge), Neal Young (Bethesda)
4th How to Diagnose and Treat LYMPHOMA 
4th How to Diagnose and Treat Lymphoma
  • Chairs : Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
  • November 1-3, 2024 - Stockholm, Sweden

SCIENTIFIC TOPICS:

- Aggressive B cell lymphomas: Diffuse large B cell lymphoma,
High grade B cell lymphoma and Burkitt
- Mantle cell lymphoma
- Challenging T cell lymphomas
- Mantle Cell lymphoma: Optimal cellular therapy for relapsed disease
CAR T vs AlloSCT
- Diffuse large B cell lymphoma
- Diffuse large B-cell lymphoma: Immune based therapy
- Novelties in marginal zone lymphoma and Waldenström macroglobulinemia
- What is the optimal regimen for advanced Hodgkin’s lymphoma?
- Chronic lymphocytic leukemia
- Follicular Lymphoma
- Bispecific VS Car-T
- Immune environment in Hodgkin’s lymphoma

 

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from February 3rd, 2025!

FACULTY MEMBERS:

Jeremy Abramson (Boston), Othman Al-Sawaf (Cologne), Luca Arcaini (Pavia), Emmanuel Bachy (Lyon), Francesco Bertoni (Bellinzona), Francesc Bosch (Barcelona), Paul J Bröckelmann (Cologne), Christian Buske (Ulm), Sylvain Carras (Grenoble), Martine Chamuleau (Amsterdam), Morgane Cheminant (Paris), Michael Crump (Toronto), Andrew Davies (Southampton), Martin Dreyling (Munich), Barbara Eichhorst (Cologne), Giuseppe Gritti (Bergamo), Steven Horwitz (New York), Margot Jak (Utrecht), Mats Jerkeman (Lund), Marie José Kersten (Amsterdam), Andrea Kuhnl (London), Ann Lacasce (Boston), François Lemonnier (Paris), Sirpa Leppä (Helsinki), Kim Linton (Manchester), Stephan Mielke (Stockholm), Jessica Okosun (London), Anca Prica (Toronto), Kai Rejeski (New York), Gilles Salles (New York), Kerry Savage (Vancouver),Christian Steidl (Vancouver), Catherine Thieblemont (Paris)
7th Translational Research Conference on MULTIPLE MYELOMA
7th Translational Research Conference on MULTIPLE MYELOMA
  • Chairs: Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch
  • October 4-6, 2024 - Mandelieu-La Napoule, France

SCIENTIFIC TOPICS:

- MGUS
- Smouldering myeloma
- Characterising multiple myeloma
- Newly diagnosed fit multiple myeloma
- Newly-diagnosed unfit myeloma patients
- Personalising treatment
- Triplets vs Immunotherapy in Early Lines of Treatment
- Late relapse
- Amyloidosis

 

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from January 7th, 2025!

FACULTY MEMBERS:

Meral Beksac (Ankara), Eileen Boyle (London), Rajshekhar Chakraborty (New York), Wee Joo Chng (Singapore), Luciano Costa (Birmingham), Francesca Gay (Turin), Hartmut Goldschmidt (Heidelberg), Jens Hillengass (Buffalo), Martin Kaiser (London), Shaji Kumar (Rochester), Ola Landgren (Miami), Suzanne Lentzsch (New York), Sham Mailankody (New York), Mohammad Mohty (Paris),Philippe Moreau (Nantes), Ajay Nooka (Atlanta), Bruno Paiva (Pamplona), Charlotte Pawlyn (London), Rakesh Popat (London), Marc Raab (Heidelberg), Noopur Raje (Boston), Paula Rodriguez-Otero (Pamplona), Pieter Sonneveld (Rotterdam), Evangelos Terpos (Athens), Sigrun Thorsteinsdottir (Reykjavik), Karin Vanderkereken (Brussels), Ashutosh Wechalekar (London)

ABOUT THE CONFERENCE:

The 7th Translational Research Conference on MULTIPLE MYELOMA allows an outstanding faculty of myeloma experts to present the most recent advances and perspectives in the field of plasma disorders from pathophysiology to diagnosis and therapy.
26th Annual John Goldman Conference on CHRONIC MYELOID LEUKAEMIA
ESH-iCMLf 26th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
  • Chairs : Jorge Cortes, Tim P. Hughes, Daniela S. Krause
  • September 27-29, 2024 - Prague, Czech Republic

Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Oliver Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa

Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, François-Xavier Mahon, Danilo Perrotti, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from December 30th!
3rd Translational Research Conference on IMMUNE & CELLULAR THERAPIES
3rd Translational Research Conference: Immune & Cellular Therapies: Focus on Advanced Gene-Engineered Immune Cells
  • Chairs : Chiara Bonini, Michael Hudecek, Stanley Riddell
  • September 13-15, 2024 - Malahide (Dublin), Ireland
  • #ESHIMMUNE2024

SCIENTIFIC TOPICS:

- Clinical development of CAR-T cell therapy
- Emerging targets for cell therapy
- Receptor engineering for tumor therapy
- Gene editing to enhance efficacy
- Novel cell types and sources – beyond autologous
- Engineering immune cells in vivo
- Correlative analyses of response and resistance
- Overcoming barriers to improve response
​- The future of engineered cell therapy
 

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from December 16th!

FACULTY MEMBERS:

Jennifer Adair (Seattle), Larry Bacon (Dublin), Adi Barzel (Tel Aviv), Halvard Bönig (Frankfurt), Chiara Bonini (Milan), Christian Buchholz (Langen), Dirk Busch (Munich), Giulia Casorati (Milan), Aude Chapuis (Seattle), Matteo Doglio (Milan), Stephen Gottschalk (Memphis), Dominic Grün (Würzburg), Michael Hudecek (Würzburg), Johannes Huppa (Berlin), Michael Jensen (Seattle), Shin Kaneko (Kyoto), Maik Luu (Würzburg), Marcela Maus (Boston), Michael O'Dwyer (Galway), Karl Petri (Würzburg), Alessia Potenza (Milan), Leo Rasche (Würzburg), Stan Riddell (Seattle), Claire Roddie (London), Marco Ruella (Philadelphia)

About the Conference:

The ESH 3rd Translational Research Conference on IMMUNE & CELLULAR THERAPIES: Focus on Advanced Gene-Engineered Immune Cells proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.

It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in immune & cellular therapies with a focus on advanced gene-engineered immune cells.
New data will be presented and spirited debates on how to best to apply these insights to the future of immune & cellular therapies are expected.
We found no results for your search. Please change or remove at least one filter to broaden your search.
eLearning Centre supported by:

What's new

#ESHMICRO2025 REGISTER NOW & JOIN US IN LONDON IN FEBRUARY!
5th Scientific Workshop
Tumour Microenvironment & its Therapeutic Targeting
February 16-18, 2025 in London, UK
Chairs: Dominique Bonnet, Nitin Jain, Marina Konopleva, Daniela S. Krause, Simon Mendez-Ferrer, Kwee Yong

#ESHERYTHRO2025 JUST A FEW DAYS LEFT TO SUBMIT YOUR ABSTRACT!
4th Translational Research Conference
Pathophysiology & Clinical Advances in Sickle Cell Disease & Thalassemi
March 14-16, 2025 in Malahide (Dublin), Ireland
Chairs : Maria Domenica Cappellini, Michaela Fontenay, Alexis A. Thompson

#ESHLCMLMPN2025 DEADLINE APPROACHING FOR ABSTRACT SUBMISSION: December 15th
SUBMIT YOURS NOW!
4th How to Diagnose and Treat CML/MPN
March 7-9, 2025 in Vienna, Austria
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa

2024 ©
EUROPEAN SCHOOL OF HAEMATOLOGY
USER TERMS AND CONDITIONS / PRIVACY POLICY
(Amended according to GDPR)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies